Eterna Therapeutics Inc (NASDAQ:ERNA) does about 616.52K shares in volume on a normal day but saw 1418881 shares change hands in the recent trading day. The company now has a market cap of 25.92M USD. Its current market price is $0.40, marking an increase of 26.19% compared to the previous close of $0.32. The 52 week high reached by this stock is $2.62 whilst the lowest price level in 52 weeks is $0.27.
Eterna Therapeutics Inc (ERNA) has a 20-day trading average at $0.6361 and the current price is -84.77% off the 52-week high compared with 50.28% distance from its 52-week low. The 50-day simple moving average of the closing price is $0.8798 and its 200-day simple moving average is $1.6431. If we look at the stock’s price movements over the week, volatility stands at 30.41%, which decreases to 19.95% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 27.83 to suggest the stock is oversold.
The consensus objective for the share price is $60.00, suggesting that the stock has a potential upside of 99.33% over the period.
The current price level is -37.13%, -54.55%, and -75.66% away from its SMA20, SMA50, and SMA200 respectively, with the ERNA price moving above the 50-day SMA on current market day. Eterna Therapeutics Inc (ERNA) stock is down -5.91% over the week and -64.29% over the past month. Its price is -77.72% year-to-date and -66.11% over the past year.
To reach the target analysts have set, the stock logically needs to grow 99.33 percent from here.
Outstanding shares total 51.37M with insiders holding 336.35% of the shares and institutional holders owning 11.00% of the company’s common stock. The company has a return on equity of -1154.18%. The beta has a value of 4.28. Price to sales ratio is 43.20.
